滬深市場個股詳情

600222 太龍藥業

添加自選

5.23
+0.01+0.19%

交易中 05/08 11:18 (北京)

30.01億總市值48.88市盈率TTM

太龍藥業股票討論區

登錄發表評論

Moomoo AI

02/06 07:35

Market expectations of a decline in Henan Taloph Pharmaceutical's revenue performance and slower growth compared to the industry average may contribute to its low P/S ratio. Shareholders' wariness of the company's ability to keep up with industry growth could be a factor in the declining share price.

Why Investors Shouldn't Be Surprised By Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) 30% Share Price Plunge

Moomoo AI

2023/10/31 08:13

Henan Taloph's lower P/S ratio may be justified due to slower growth rates than industry rivals. Doubts about the company's ability to maintain robust growth in line with industry may hinder share price recovery.

Little Excitement Around Henan Taloph Pharmaceutical Stock Co.,Ltd's (SHSE:600222) Revenues

暫無評論

分析

分析師評級

暫無數據

目標價預測

暫無數據

熱議

滬深

綜合熱度